Alpha2C-adrenoceptor mediated regulation of cortical EEG arousal

Neuropharmacology

Volumn 43, Issue 8, 2002, Pages 1305-1312

  Puoliväli, Jukka ^a   Björklund, Markus ^a   Holmberg, Maya ^b   Ihalainen, Jouni A ^a   Scheinin, Mika ^b   Tanila, Heikki ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Alpha2C adrenoceptors; Atipamezole; Dexmedetomidine; EEG slowing; Knockout mice; Sedation

Indexed keywords

ALPHA 2C ADRENERGIC RECEPTOR; ATIPAMEZOLE; CHOLINE ACETYLTRANSFERASE; DEXMEDETOMIDINE; MONOAMINE; RECEPTOR SUBTYPE; ADRENERGIC RECEPTOR ALPHA(2C); ALPHA 2 ADRENERGIC RECEPTOR; IMIDAZOLE DERIVATIVE;

AROUSAL; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; FEMALE; GENOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; THALAMUS; THETA RHYTHM; ANIMAL; BRAIN; C57BL MOUSE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; AROUSAL; BRAIN; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; IMIDAZOLES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0036883232     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00305-2     Document Type: Article

References (26)

1. Aantaa R., Scheinin M. Alpha 2-adrenergic agents in anaesthesia. Acta Anaesthesiologia Scandinavica. 37:1993;433-448.
2. Björklund M., Sirviö J., Puoliväli J., Sallinen J., Jäkälä P., Scheinin M., Kobilka B.K., Riekkinen P. Jr. Alpha2C-adrenoceptor-overexpressing mice are impaired in executing nonspatial and spatial escape strategies. Molecular Pharmacology. 54:1998;569-576.
3. Bol C., Danhof M., Stanski D.R., Mandema J.W. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. The Journal of Pharmacology and Experimental Therapeutics. 283:1997;1051-1058.
4. Buzsaki G., Kennedy B., Solt V.B., Ziegler M. Noradrenergic control of thalamic oscillation: the role of alpha-2 receptors. European Journal of Neuroscience. 3:1991;222-229.
5. Correa-Sales C., Rabin B.C., Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology. 76:1992;948-952.
6. 2C-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. The Journal of Pharmacology and Experimental Therapeutics. 300:2002;282-290.
7. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. Journal of Neurochemistry. 24:1975;407-409.
8. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego, CA.
9. Gerlai R. Gene targeting: technical confounds and potential solutions in behavioral brain research. Behavioral Brain Research. 125:2001;13-21.
10. Holmberg M., Scheinin M., Kurose H., Miettinen R. Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry. Neuroscience. 93:1999;1323-1333.
11. Hunter J.C., Fontana D.J., Hedley L.R., Jasper J.R., Lewis R., Link R.E., Secchi R., Sutton J., Eglen R.M. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. British Journal of Pharmacology. 122:1997;1339-1344.
12. Jäkälä P., Sirviö J., Jolkkonen J., Riekkinen P. Jr., Acsady L., Riekkinen P. The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behavioral Brain Research. 51:1992;29-40.
13. Jäkälä P., Viitamaa T., Sirviö J., Riekkinen P. Jr., Salonen J., Haapalinna A., Virtanen R., Riekkinen P. Continuous alpha 2-adrenoceptor blockade by atipamezole decreases neocortical high-voltage spindle activity in rats. European Journal of Pharmacology. 221:1992;351-357.
14. Lakhlani P.P., MacMillan L.B., Guo T.Z., McCool B.A., Lovinger D.M., Maze M., Limbird L.E. Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proceedings of the National Academy of Sciences of the United States of America. 94:1997;9950-9955.
15. Lee A., Wissekerke A.E., Rosin D.L., Lynch K.R. Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience. 84:1998;1085-1096.
16. Link R.E., Stevens M.S., Kulatunga M., Scheinin M., Barsh G.S., Kobilka B.K. Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog. Molecular Pharmacology. 48:1995;48-55.
17. Millan M.J., Dekeyne A., Newman-Tancredi A., Cussac D., Audinot V., Milligan G., Duqueyroix D., Girardon S., Mullot J., Boutin J.A., Nicolas J.P., Renouard-Try A., Lacoste J.M., Cordi A. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. The Journal of Pharmacology and Experimental Therapeutics. 295:2000;1192-1205.
18. Millan M.J., Lejeune F., Gobert A., Brocco M., Auclair A., Bosc C., Rivet J.M., Lacoste J.M., Cordi A., Dekeyne A. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. The Journal of Pharmacology and Experimental Therapeutics. 295:2000;1206-1222.
19. Mizobe T., Maze M. Alpha 2-adrenoceptor agonists and anesthesia. International Anesthesiology Clinics. 33:1995;81-102.
20. Nicholas A.P., Pieribone V., Hokfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. Journal of Comparative Neurology. 328:1993;575-594.
21. Paxinos G., Franklin K.B.J. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, San Diego, CA.
22. Riekkinen P. Jr., Lammintausta R., Ekonsalo T., Sirviö J. The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats. European Journal of Pharmacology. 238:1993;63-272.
23. Ruffolo R.R. Jr., Nichols A.J., Stadel J.M., Hieble J.P. Structure and function of alpha-adrenoceptors. Pharmacological Reviews. 43:1991;475-505.
24. Sallinen J., Link R.E., Haapalinna A., Viitamaa T., Kulatunga M., Sjoholm B., Macdonald E., Pelto-Huikko M., Leino T., Barsh G.S., Kobilka B.K., Scheinin M. Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective allpha 2-adrenoceptor agonist. Molecular Pharmacology. 51:1997;36-46.
25. Scheinin M., Lomasney J.W., Hayden-Hixson D.M., Schambra U.B., Caron M.G., Lefkowitz R.J., Fremeau R.T. Jr. Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Molecular Brain Research. 21:1994;133-149.
26. Schramm N.L., McDonald M.P., Limbird L.E. The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. Journal of Neuroscience. 21:2001;4875-4882.